...
首页> 外文期刊>Cell stem cell >Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal Infection Response to SARS-CoV-2
【24h】

Three-Dimensional Human Alveolar Stem Cell Culture Models Reveal Infection Response to SARS-CoV-2

机译:三维人肺泡干细胞培养模型揭示了对SARS-COV-2的感染反应

获取原文
获取原文并翻译 | 示例
           

摘要

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is the cause of a present pandemic, infects human lung alveolar type 2 (hAT2) cells. Characterizing pathogenesis is crucial for developing vaccines and therapeutics. However. the lack of models mirroring the cellular physiology and pathology of hAT2 cells limits the study. Here, we develop a feeder-free, long-term, three-dimensional (3D) culture technique for hAT2 cells derived from primary human lung tissue and investigate infection response to SARS-CoV-2. By imaging-based analysis and single-cell transcriptome profiling, we reveal rapid viral replication and the increased expression of interferon-associated genes and proinflammatory genes in infected hAT2 cells, indicating a robust endogenous innate immune response. Further tracing of viral mutations acquired during transmission identifies full infection of individual cells effectively from a single viral entry. Our study provides deep insights into the pathogenesis of SARS-CoV-2 and the application of defined 3D hAT2 cultures as models for respiratory diseases.
机译:严重急性呼吸综合征冠状病毒2(SARS-CoV-2)是目前大流行的原因,感染人肺泡2型(hAT2)细胞。确定发病机制对于开发疫苗和治疗方法至关重要。然而缺乏反映hAT2细胞的细胞生理学和病理学的模型限制了这项研究。在这里,我们开发了一种无饲养、长期、三维(3D)培养技术,用于从原代人肺组织中提取hAT2细胞,并研究SARS-CoV-2的感染反应。通过基于成像的分析和单细胞转录组分析,我们揭示了病毒的快速复制,以及在感染的hAT2细胞中干扰素相关基因和促炎基因的表达增加,表明了一种强大的内源性固有免疫应答。对传播过程中获得的病毒突变进行进一步追踪,可以有效地从单个病毒入口识别单个细胞的完全感染。我们的研究对SARS-CoV-2的发病机制以及定义的3D hAT2培养物作为呼吸道疾病模型的应用提供了深入的见解。

著录项

  • 来源
    《Cell stem cell》 |2020年第6期|共25页
  • 作者单位

    Korea Adv Inst Sci &

    Technol Grad Sch Med Sci &

    Engn Daejeon 34141 South Korea;

    Korea Adv Inst Sci &

    Technol Grad Sch Med Sci &

    Engn Daejeon 34141 South Korea;

    Univ Cambridge Jeffrey Cheah Biomed Ctr Wellcome MRC Cambridge Stem Cell Inst Cambridge CB2 A0W;

    Korea Ctr Dis Control &

    Prevent Korea Natl Inst Hlth Ctr Infect Dis Res Div Viral Dis Res;

    Korea Adv Inst Sci &

    Technol BioMed Res Ctr Daejeon 34141 South Korea;

    Inst for Basic Sci Korea Ctr Vasc Res Daejeon 34126 South Korea;

    Korea Ctr Dis Control &

    Prevent Korea Natl Inst Hlth Ctr Infect Dis Res Div Viral Dis Res;

    Korea Adv Inst Sci &

    Technol Grad Sch Med Sci &

    Engn Daejeon 34141 South Korea;

    Korea Adv Inst Sci &

    Technol Grad Sch Med Sci &

    Engn Daejeon 34141 South Korea;

    Seoul Natl Univ Seoul Natl Univ Hosp Canc Res Inst Dept Thorac &

    Cardiovasc Surg Seoul 03080;

    Natl Inst Biol Stand &

    Controls Blanche Lane Potters Bar EN6 3QG Herts England;

    Korea Adv Inst Sci &

    Technol Grad Sch Med Sci &

    Engn Daejeon 34141 South Korea;

    AstraZeneca R&

    D Clin Pharmacol &

    Safety Sci Cambridge England;

    Univ Cambridge Dept Surg Biomed Campus Cambridge CB2 2QQ England;

    Univ Cambridge Dept Surg Biomed Campus Cambridge CB2 2QQ England;

    Chungnam Natl Univ Coll Med Dept Lab Med Daejeon 35015 South Korea;

    Seoul Natl Univ Seoul Natl Univ Hosp Canc Res Inst Dept Thorac &

    Cardiovasc Surg Seoul 03080;

    Inst for Basic Sci Korea Ctr Vasc Res Daejeon 34126 South Korea;

    Korea Ctr Dis Control &

    Prevent Korea Natl Inst Hlth Ctr Infect Dis Res Div Viral Dis Res;

    Korea Adv Inst Sci &

    Technol Grad Sch Med Sci &

    Engn Daejeon 34141 South Korea;

    Univ Cambridge Jeffrey Cheah Biomed Ctr Wellcome MRC Cambridge Stem Cell Inst Cambridge CB2 A0W;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 细胞生物学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号